LIGHTSITE II RANDOMIZED MULTICENTER TRIAL:EVALUATION OF MULTIWAVELENGTH PHOTOBIOMODULATIONIN NON-EXUDATIVE AGE-RELATED MACULAR DEGENERATION
Introduction: Photobiomodulation (PBM) represents a potential treatment for non-exudative age-related macular degeneration (AMD). PBM uses wavelengths of light to target components of the mitochondrial respiratory chain to improve cellular bioenergetic outputs. The aim of this study was to further investigate the effects of PBM on clinical, quality of life (QoL) and anatomical outcomes in subjects with intermediate stage non-exudative AMD. Leia mais